Becton Dickinson and Co vs GameStop Corp. — how do they compare? Becton Dickinson and Co trades at $154.29 (market cap $41.51B), while GameStop Corp. trades at $22.42 (market cap $10.06B). The key difference: Becton Dickinson and Co is far larger — about 4.1× GameStop Corp.'s market cap, and Becton Dickinson and Co pays a 2.79% dividend while GameStop Corp. pays none. Which is the better fit depends on your goals.
| BDX | GME | |
|---|---|---|
Market Cap | $41.51B | $10.06B |
Sector | Health | Consumer Cyclical |
52-Week High | $185.39 | $27.69 |
52-Week Low | $135.49 | $19.94 |
Enterprise Value | $57.97B | $6.04B |
Dividend Yield | 2.79% | — |
Signals from Pluang's Aura AI — not financial advice
BDX trades at $153.83, up 1.24% today, with technical indicators showing a neutral to bullish bias. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $2.90 exceeding expectations. Revenue growth remains steady, reaching $21.84B in 2025, though net margins have compressed to 5.12%. Recent news highlights BDX's innovation in medical technology and positive analyst sentiment.
The outlook for BDX appears balanced. Upside potential exists from continued earnings beats and strategic positioning in growing healthcare segments like GLP-1 drug support equipment. However, risks include margin pressure, elevated debt levels, and cautious hospital spending. The consensus price target of $173.40 suggests moderate upside from current levels.
GME trades at $22.03, up 1.61% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.30 exceeding the $0.16 estimate. Revenue for 2025 was $3.82 billion, with net income of $131.3 million and a profit margin of 3.43%. Recent news highlights the proposed eBay acquisition and a robust EBITDA outlook exceeding $600 million for fiscal 2026.
The outlook is mixed; fundamental improvements in profitability and strategic moves like the eBay bid offer potential upside, but bearish technicals and a majority hold rating from analysts suggest caution. Key risks include execution of the acquisition, competitive pressures from digital game distribution, and reliance on collectibles growth.
Trailing returns across standard periods
Latest headlines on both assets
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →Global Market Group Ltd. operates an Internet website that connects Chinese manufacturers with international buyers. The Company's customers can post company profiles and product information in standardized formats; post product listings; and trade leads.
Read more on GME →